Samsung Biologics Q2 net income up 72 pct to 318 bln won
Samsung Biologics Co. on Wednesday reported its second-quarter net income of 318 billion won (US$229.8 million), up 72 percent from a year earlier.
The company said in a regulatory filing that operating income for the April-June period rose 71.4 per…